AK

Abirami Karpagam Anand

Active Director Director DIN 10301610
DIN 10301610 First appointment Aug 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Abirami Karpagam Anand

Data last updated:

Abirami Karpagam Anand is a Director at Dr.Kannan's Gastromed Hospital Private Limited (since 2023). The company operates in Healthcare.

DIN 10301610
Primary Designation Director
Industry Healthcare
First Appointment 31 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Aug 20232023Active

Board colleagues of Abirami Karpagam Anand

NameDINCompanyDesignation
Kannan Anand10301611Dr.Kannan's Gastromed Hospital Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Dr.Kannan's Gastromed Hospital Private Limited
Premium access

Shareholding and investment profile for Abirami Karpagam Anand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abirami Karpagam Anand

Abirami Karpagam Anand currently holds 1 directorship: Dr.Kannan's Gastromed Hospital Private Limited (Director, since 31 Aug 2023).

Abirami Karpagam Anand was first appointed on 31 Aug 2023 as Director at Dr.Kannan's Gastromed Hospital Private Limited.

The current boards of Abirami Karpagam Anand's companies include Kannan Anand (Dr.Kannan's Gastromed Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available